| View |
|
DRP-11927-07
|
Meropenem
|
Merostan
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
07 October 2024
|
20 May 2027
|
| View |
|
DRP-11965-02
|
Dobutamine (as hydrochloride)
|
Dobusan
|
50 mg/mL
|
Solution for Injection (IV)
|
Adrenergic and Dopaminergic Agent
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
12 October 2024
|
24 May 2027
|
| View |
|
DRP-12037-08
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
Maedgliptin
|
50 mg/1 g
|
Film-Coated Tablet
|
Dipeptidyl peptidase 4 (DPP-4) inhibitor/Blood glucose lowering drug (Biguanide)
|
Sai Mirra Innopharm Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 October 2024
|
02 June 2027
|
| View |
|
DRP-12192-06
|
Co-Amoxiclav
|
Co-Enzoclav
|
457 mg/ 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
07 October 2024
|
02 September 2027
|
| View |
|
DRP-12192-07
|
CO-AMOXICLAV
|
AMOICLAV
|
457 mg/5 mL
|
POWDER FOR SUSPENSION
|
ANTIBACTERIAL (PENICILLIN)
|
J.M. TOLMANN LABORATORIES, INC.
|
Philippines
|
CLIDP Conversion
|
12 October 2024
|
02 September 2027
|
| View |
|
DRP-12217-01
|
Iodine (as Iohexol)
|
Radiostar-300
|
|
Solution for Injection
|
Iodinated X-Ray Contrast Media
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
01 July 2027
|
| View |
|
DRP-12218-01
|
Iodine (as Iohexol)
|
Radiostar-350
|
|
Solution for Injection
|
Iodinated X-Ray Contrast Media
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
07 October 2024
|
01 July 2027
|
| View |
|
DRP-12767-01
|
Ivabradine (as hydrochloride)
|
Gavrila
|
5mg
|
Film-Coated Tablet
|
Cardiac Preparation
|
Bafna Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
12 October 2024
|
05 October 2027
|
| View |
|
DRP-13009-02
|
Irbesartan
|
Irbevex 300
|
300 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
10 October 2024
|
17 November 2027
|
| View |
|
DRP-13010-02
|
Irbesartan
|
Irbevex 150
|
150 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
12 October 2024
|
17 November 2027
|
| View |
|
DRP-13202-02
|
Methylprednisolone (as sodium succinate)
|
Predyl 1000
|
1g
|
Lyophilized Powder for Injection (I.M./I.V.)
|
Glucocorticoid
|
East African (India) Overseas
|
India
|
CLIDP Conversion
|
12 October 2024
|
28 December 2027
|
| View |
|
DRP-13203-01
|
Methylprednisolone (as sodium succinate)
|
Predyl 40
|
40 mg
|
Lyophilized Powder for Injection (I.M./I.V.)
|
Glucocorticoid
|
East African (India) Overseas
|
India
|
CLIDP Conversion
|
09 October 2024
|
28 December 2027
|
| View |
|
DRP-13704-03
|
Betahistine hydrochloride
|
Histyn
|
16 mg
|
Tablet
|
Antivertigo preparation
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 October 2024
|
29 March 2028
|
| View |
|
DRP-14223-02
|
Ascorbic Acid + Zinc
|
Asconvitazin
|
100 mg (equivalent to 112.5mg Sodium Ascorbate)/ 10 mg (equivalent to 27.5mg Zinc Sulfate Monohydrate) per 5mL
|
Oral Syrup
|
Vitamin/Mineral
|
St. Martin Pharm Lab Co.
|
Philippines
|
CLIDP Conversion
|
12 October 2024
|
30 January 2027
|
| View |
|
DRP-14287-01
|
Levodropropizine
|
Prozrich
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
11 August 2028
|
| View |
|
DRP-14353-01
|
Ketoconazole + Clobetasol Propionate
|
KCP Cream
|
10 mg/500 mcg per gram
|
Cream
|
Antifungal (Imidazole and triazole derivative)/ Corticosteroid
|
Azine Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 October 2024
|
24 August 2028
|
| View |
|
DRP-14392-01
|
Telmisartan + Amlodipine (as besilate)
|
None
|
80 mg/10 mg
|
Tablet
|
Angiotension II Receptor Blocker (ARB) / Calcium Channel Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
12 October 2024
|
31 August 2028
|
| View |
|
DRP-14549
|
Cefixime (as trihydrate)
|
Bhecxime
|
100 mg / 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Baroque Pharmaceuticals Pvt. Ltd
|
India
|
Renewal
|
07 October 2024
|
10 February 2030
|
| View |
|
DRP-14857-01
|
Clindamycin phosphate
|
Cezclin
|
20 mg / mL
|
Topical Solution
|
Antibacterial (Lincosamide)
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
13 September 2025
|
| View |
|
DRP-14964-02
|
Mupirocin
|
Mupirocare
|
20 mg/g (2% w/w)
|
Topical Ointment
|
Antibiotic for Topical Use
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 October 2024
|
07 March 2029
|